Pankaj Singh-Kumar

Hyderabad, TG 500037, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Human serum albumin-based polymeric nanoparticles for ratiometric co-encapsulation and co-delivery of palbociclib and tamoxifen citrate for synergistic effect in breast cancer management.

Human serum albumin-based polymeric nanoparticles for ratiometric co-encapsulation and co-delivery of palbociclib and tamoxifen citrate for synergistic effect in breast cancer management.

Journal: International journal of biological macromolecules

Published: January 15, 2026

Human Serum Albumin-Lipid Nanocapsules of Duvelisib for Hematological Cancers: Characterization, In-Vitro Cell-Culture, Toxicity and Pharmacokinetic Studies.

Human Serum Albumin-Lipid Nanocapsules of Duvelisib for Hematological Cancers: Characterization, In-Vitro Cell-Culture, Toxicity and Pharmacokinetic Studies.

Journal: AAPS PharmSciTech

Published: June 21, 2025

Bovine serum albumin capped lipid nanosystem bearing CDK4/6 inhibitor to combat breast cancer: In-vitro and In-vivo assessment.

Bovine serum albumin capped lipid nanosystem bearing CDK4/6 inhibitor to combat breast cancer: In-vitro and In-vivo assessment.

Journal: International journal of biological macromolecules

Published: June 07, 2025

Fabrication of Second-Generation Acalabrutinib Nanocrystals by Employing the Nano-Edge Method for Improving the Physico-Chemical Properties and Forecasting their In-Silico Pharmacokinetic Behaviour.

Fabrication of Second-Generation Acalabrutinib Nanocrystals by Employing the Nano-Edge Method for Improving the Physico-Chemical Properties and Forecasting their In-Silico Pharmacokinetic Behaviour.

Journal: AAPS PharmSciTech

Published: May 29, 2025

Benchmarking of pH-responsive mixed micelles for repurposed breast cancer therapy of ibrutinib with molecular modeling and pharmacokinetic insights.

Benchmarking of pH-responsive mixed micelles for repurposed breast cancer therapy of ibrutinib with molecular modeling and pharmacokinetic insights.

Journal: Journal of materials chemistry. B

Published: May 22, 2025

Enhancing oral bioavailability of pazopanib via co-amorphous system: Formulation, characterization, pharmacokinetics and toxicity evaluation.

Enhancing oral bioavailability of pazopanib via co-amorphous system: Formulation, characterization, pharmacokinetics and toxicity evaluation.

Journal: Colloids and surfaces. B, Biointerfaces

Published: April 25, 2025

Mucoadhesive Carbohydrate-Based Polymeric Nanocapsule Loaded with Palbociclib for Enhanced GIT Retention and In Vitro Anticancer Efficacy in MDA-MB-231 Cells.

Mucoadhesive Carbohydrate-Based Polymeric Nanocapsule Loaded with Palbociclib for Enhanced GIT Retention and In Vitro Anticancer Efficacy in MDA-MB-231 Cells.

Journal: AAPS PharmSciTech

Published: April 11, 2025

Corrigendum to "Harnessing the targeting potential of hyaluronic acid for augmented anticancer activity and safety of duvelisib-loaded nanoparticles in hematological malignancies" [Int. J. Biol. Macromol. 282 (2024) 136600].

Corrigendum to "Harnessing the targeting potential of hyaluronic acid for augmented anticancer activity and safety of duvelisib-loaded nanoparticles in hematological malignancies" [Int. J. Biol. Macromol. 282 (2024) 136600].

Journal: International journal of biological macromolecules

Published: December 03, 2024

Contemplating Novel W/O Emulsion Based Gel for Anti-Psoriatic Activity of Tofacitinib in Imiquimod-Induced Balb/C Mice Model.

Contemplating Novel W/O Emulsion Based Gel for Anti-Psoriatic Activity of Tofacitinib in Imiquimod-Induced Balb/C Mice Model.

Journal: AAPS PharmSciTech

Published: August 22, 2024

The Neoteric Paradigm of Biomolecule-Functionalized Albumin-Based Targeted Cancer Therapeutics.

The Neoteric Paradigm of Biomolecule-Functionalized Albumin-Based Targeted Cancer Therapeutics.

Journal: AAPS PharmSciTech

Published: July 31, 2024

Harnessing the targeting potential of hyaluronic acid for augmented anticancer activity and safety of duvelisib-loaded nanoparticles in hematological malignancies.

Harnessing the targeting potential of hyaluronic acid for augmented anticancer activity and safety of duvelisib-loaded nanoparticles in hematological malignancies.

Journal: International journal of biological macromolecules

Published: July 03, 2024

Manifesting the Dasatinib-gallic acid co-amorphous system to augment anticancer potential: Physicochemical characterization, in silico molecular simulation, ex vivo permeability, and in vitro efficacy.

Manifesting the Dasatinib-gallic acid co-amorphous system to augment anticancer potential: Physicochemical characterization, in silico molecular simulation, ex vivo permeability, and in vitro efficacy.

Journal: International journal of pharmaceutics

Published: June 20, 2024

Showing 1-12 of 25

Last Updated: 09/26/2026